Evidence map›Paper›PMID 42351650›Full record

ArticleBiomedicines2026

A Gene Feature Based on Histone Modifications Can Predict the Prognosis of Prostate Cancer.

Jialin Gao, Xuee Zhou, Zetao Zuo, Jiahong Hong, Yan Tan, Xiaoxiang Rong, Rui Zhou, Zhenhua Huang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jialin GaoDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.ORCID 0009-0005-3509-5163
Xuee ZhouDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Zetao ZuoDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Jiahong HongDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Yan TanDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Xiaoxiang RongDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Rui ZhouDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Zhenhua HuangDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.

Funding

China Postdoctoral Science Foundation 2019M663001National Natural Science Foundation of China 82073375Natural Science Foundation of Guangdong Province 2021A1515010700Science and Technology Planning Project of Guangzhou 202102020532
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

histone modificationnomogramprediction modelprognosisprostate cancer

Identifiers

PMID42351650
PMCPMC13296647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.